Stephens analyst Drew Jones reiterated a Buy rating on Brooks Automation (BRKS) on November 26 and set a price target of $43. The company’s shares closed yesterday at $30.72.
According to TipRanks.com, Jones is a 5-star analyst with an average return of 18.3% and a 62.7% success rate. Jones covers the Healthcare sector, focusing on stocks such as Bio-Techne Corporation, Orasure Technologies, and Ligand Pharma.
Currently, the analyst consensus on Brooks Automation is a Strong Buy with an average price target of $36.50, representing a 18.8% upside. In a report issued on November 20, B.Riley FBR also maintained a Buy rating on the stock with a $42 price target.
.
See today’s analyst top recommended stocks >>
The company has a one-year high of $39.75 and a one-year low of $21.75. Currently, Brooks Automation has an average volume of 846.9K.
Based on the recent corporate insider activity of 83 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Brooks Automation, Inc. engages in the provision of automation and cryogenic solutions for multiple markets, including semiconductor capital equipment and life science biological sample management and storage. It operates through the Brooks Semiconductor Solutions Group; and Brooks Life Science Systems segments.
